Medicare Enrolled

Ralph Gousse, M. D.

Hematology · Altamonte Springs, FL
Practice pattern: Mixed Practice — Diverse clinical practice across multiple procedure types
106 BOSTON AVE STE 105, Altamonte Springs, FL 32701
4075537710
Registered in NPPES since 2006
NPI: 1457316341 verify on NPPES ↗
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Gousse from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Gousse? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Gousse

Ralph Gousse is a hematology specialist in Altamonte Springs, FL, with 20 years of NPI registration. Based on federal Medicare data, Gousse performed 183,759 Medicare services in 2023. These records do not provide a deduplicated patient total.

Between the years covered by Open Payments, Gousse received a total of $7,813 from 62 pharmaceutical and/or device companies across 411 payment records. A record can group multiple payments. These transfers are publicly reported through CMS Open Payments. Disclosure alone does not establish their effect on care. A reliable breakdown by payment category is not available in this snapshot. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Gousse is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 20 years of NPI registration ▲ Top 25% volume in FL $7,813 industry payments

Medicare Practice Summary — 2023

Medicare Utilization ↗
183,759
Medicare services
Top 25% in FL for hematology
Not available
Unique patients (not deduplicated)
$6
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →

Top procedures by volume

Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.

Procedure Volume Avg. paid Avg. submitted
Iron infusion (Feraheme)
An injection of ferumoxytol used to treat iron deficiency anemia in patients not on dialysis.
66,300 $0 $4
Iron infusion (Injectafer)
An intravenous injection of ferric carboxymaltose, an iron replacement medication.
30,750 $1 $3
Iron sucrose injection (Venofer)
An injection of iron sucrose used to replenish iron levels in the body.
24,100 $0 $5
Epoetin alfa injection (Procrit) for anemia
An injection of epoetin alfa containing 1000 units for use in patients not on end-stage renal disease (ESRD) dialysis.
18,630 $6 $23
Denosumab injection (Prolia/Xgeva) 12,240 $18 $51
Immune globulin infusion (Gammagard)
An injection of immune globulin (Gammagard Liquid) to provide antibodies. The dose specified is 500 mg.
8,330 $36 $108
Blood draw (venipuncture)
Insertion of a needle into a vein to collect a blood sample.
3,627 $8 $9
Complete blood count (CBC) with differential
An automated laboratory test that measures the levels of red blood cells, white blood cells, and platelets in the blood, including a breakdown of the different types of white blood cells.
3,360 $8 $29
Eflapegrastim injection, 0.1 mg
An injection of eflapegrastim-xnst administered at a dose of 0.1 mg.
3,036 $26 $116
Dexamethasone injection (steroid)
An injection of dexamethasone sodium phosphate, a corticosteroid medication, administered in a dose of 1 milligram.
2,700 $0 $3
Iron infusion (Monoferric) 1,800 $17 $57
Drug injection, under skin or into muscle
A procedure involving the administration of a medication or substance via injection into the subcutaneous tissue or muscle.
1,405 $10 $69
Office visit, established patient (20-29 min)
An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition.
1,250 $64 $239
Anti-nausea injection (Aloxi/palonosetron) 710 $1 $28
Office visit, established patient (30-39 min)
A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition.
704 $96 $339
Vitamin B-12 injection
An injection of vitamin B-12 (cyanocobalamin) with a dose of up to 1000 mcg.
539 $1 $6
Intravenous infusion, 1 hour or less
Administration of medication or fluid directly into a vein for therapeutic, preventive, or diagnostic purposes. The procedure lasts one hour or less.
521 $46 $189
Intravenous injection of additional new drug or substance
Administration of an additional new medication or substance directly into a vein.
508 $11 $61
Anti-nausea injection (ondansetron/Zofran) 416 $0 $9
Intravenous chemotherapy infusion, 1 hour or less
Administration of chemotherapy medication directly into a vein. The procedure takes one hour or less to complete.
359 $97 $378
Zoledronic acid injection, 1 mg
An injection of zoledronic acid administered at a dose of 1 mg.
291 $6 $69
Diphenhydramine injection, up to 50 mg
An injection of diphenhydramine hydrochloride, an antihistamine medication, administered in a dose of up to 50 milligrams.
250 $1 $3
Additional hour of intravenous infusion
This code represents each additional hour of intravenous infusion beyond the initial hour for therapy, prevention, or diagnosis.
234 $15 $56
Additional sequential IV infusion, 1 hour or less
This code represents an additional intravenous infusion administered sequentially to a primary infusion. It covers the administration time of one hour or less.
212 $21 $84
Prothrombin time test (blood clotting)
A laboratory test that measures how long it takes for blood to clot. This procedure evaluates the body's coagulation process.
145 $4 $15
Methylprednisolone injection, up to 40 mg
An injection of methylprednisolone sodium succinate, a corticosteroid medication, administered in a dose of up to 40 mg.
133 $3 $11
Non-hormonal chemotherapy injection
This procedure involves administering non-hormonal anti-neoplastic chemotherapy medication via injection into the skin or muscle tissue.
120 $55 $206
Automated red blood cell count with calculations
A blood test that automatically counts red blood cells and performs additional calculations to assess blood health.
101 $5 $20
Hospital follow-up visit, high complexity
Subsequent hospital inpatient or observation care for an existing patient involving high-level medical decision making, with at least 50 minutes total time on the date of the encounter.
92 $94 $285
Subcutaneous or intramuscular chemotherapy injection
This procedure involves administering anti-cancer hormonal medication through an injection into the tissue under the skin or into a muscle.
91 $24 $89
New patient office visit (30-44 min)
An initial office visit for a new patient lasting between 30 and 44 minutes. This code is used when the total time spent on the date of the encounter falls within this range.
89 $74 $298
New patient office visit (45-59 min)
An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter.
79 $124 $453
Additional hour of intravenous chemotherapy
This code represents the administration of chemotherapy medication into a vein for each additional hour beyond the initial period.
78 $21 $79
Office visit for established patient
An office visit for an existing patient that may not require the healthcare professional to be present.
78 $16 $59
Intravenous drug injection
A procedure involving the administration of a medication or substance directly into a vein.
76 $27 $156
Intravenous infusion of new drug or substance, 1 hour or less
This procedure involves administering a new medication or substance directly into a vein through an existing access site. The infusion is completed within one hour or less.
58 $49 $178
Initial hospital admission, high complexity
Initial hospital inpatient or observation care for a new patient involving high-level medical decision making, with at least 75 minutes total time on the date of the encounter.
58 $137 $556
Normal saline infusion, 1000 cc
Administration of 1000 cc of normal saline solution into a vein. This procedure involves the intravenous delivery of a sterile saltwater solution.
51 $2 $7
Office visit, established patient, complex (40-54 min)
An office or outpatient visit for an existing patient lasting between 40 and 54 minutes. This level of service is determined by the total time spent on the date of the encounter.
49 $136 $474
Automated urinalysis
An automated laboratory test performed on a urine sample to analyze its chemical and physical properties. The procedure uses machinery to detect various substances and cells within the urine.
46 $2 $8
Venipuncture for blood collection
A procedure to draw blood from a vein for medical testing or analysis.
42 $70 $277
Additional hour of intravenous hydration
This code represents each additional hour of intravenous fluid administration beyond the initial hour. It is used to bill for extended hydration therapy.
39 $10 $42
Intravenous hydration infusion, 31-60 minutes
Administration of fluids into a vein to maintain hydration. This procedure involves an infusion lasting between 31 and 60 minutes.
24 $25 $156
Bone marrow biopsy and aspiration
A procedure to remove a small sample of bone marrow and liquid for laboratory testing. The sample is analyzed to help diagnose various medical conditions.
21 $129 $467
Normal saline infusion, 500 ml
Administration of sterile normal saline solution through an intravenous line. This procedure involves the infusion of a 500 ml unit of the solution.
17 $1 $7
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. These counts do not measure clinical quality or years of experience.
59.1% high complexity
35.6% medium
5.3% routine

Industry Payment Transparency

Open Payments through 2024 ↗
$7,813
Total received (2018-2024)
Avg $1,116/year across 7 years
Top 48% in FL for hematology
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
62
Companies
411
Payment records
Payments are publicly reported; disclosure does not establish legality · Not evidence of wrongdoing · How to interpret →

Payment categories are unavailable while the source breakdown is being rebuilt. Company and year totals do not identify how much belongs to each category.

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$1,970
2023
$1,963
2022
$1,365
2021
$474
2020
$362
2019
$932
2018
$748

Payments by company (2024)

Gilead Sciences, Inc.
$236
Celgene Corporation
$197
PFIZER INC.
$194
Novartis Pharmaceuticals Corporation
$190
Astellas Pharma US Inc
$144
AstraZeneca Pharmaceuticals LP
$137
E.R. Squibb & Sons, L.L.C.
$93
Merck Sharp & Dohme LLC
$68
Daiichi Sankyo Inc.
$55
SOBI, INC
$53
Genentech USA, Inc.
$53
Karyopharm Therapeutics Inc.
$48
Rigel Pharmaceuticals, Inc.
$45
Blueprint Medicines Corporation
$40
ADC Therapeutics America, Inc.
$37
BeiGene USA, Inc.
$37
Exelixis Inc.
$36
ARRAY BIOPHARMA INC
$36
EMD Serono, Inc.
$29
PharmaEssentia USA Corporation
$26
Dendreon Pharmaceuticals LLC
$23
Incyte Corporation
$22
Kite Pharma, Inc.
$21
GlaxoSmithKline, LLC.
$21
GENZYME CORPORATION
$20
Pharmacosmos Therapeutics Inc.
$18
Janssen Biotech, Inc.
$17
TerSera Therapeutics LLC
$16
JAZZ PHARMACEUTICALS INC.
$15
CSL Behring
$15
Eisai Inc.
$14
SERVIER PHARMACEUTICALS LLC
$14
Top 3 companies account for 31.8% of 2024 payments
All-time payments by company (2018-2024) ›
Janssen Biotech, Inc.
$695
Celgene Corporation
$664
Novartis Pharmaceuticals Corporation
$638
E.R. Squibb & Sons, L.L.C.
$564
PFIZER INC.
$521
Genentech USA, Inc.
$426
Gilead Sciences, Inc.
$374
Astellas Pharma US Inc
$230
AstraZeneca Pharmaceuticals LP
$211
Amgen Inc.
$210
Apellis Pharmaceuticals, Inc.
$205
Pharmacyclics LLC, An AbbVie Company
$195
Kite Pharma, Inc.
$175
Incyte Corporation
$170
Karyopharm Therapeutics Inc.
$166
Seagen Inc.
$166
Exelixis Inc.
$161
Merck Sharp & Dohme LLC
$152
JAZZ PHARMACEUTICALS INC.
$140
TESARO, Inc.
$124
Daiichi Sankyo Inc.
$98
Merck Sharp & Dohme Corporation
$96
Coherus Biosciences Inc.
$95
Rigel Pharmaceuticals, Inc.
$92
BeiGene USA, Inc.
$85
EMD Serono, Inc.
$84
GlaxoSmithKline, LLC.
$75
EISAI INC.
$69
G1 Therapeutics, Inc.
$56
TerSera Therapeutics LLC
$55
SOBI, INC
$53
Eisai Inc.
$52
Global Blood Therapeutics, Inc.
$47
PharmaEssentia USA Corporation
$46
Mirati Therapeutics, Inc.
$45
Blueprint Medicines Corporation
$40
ADC Therapeutics America, Inc.
$37
GENZYME CORPORATION
$37
ABBVIE INC.
$37
ARRAY BIOPHARMA INC
$36
INSYS Therapeutics Inc
$35
Sun Pharmaceutical Industries Inc.
$28
Aurobindo Pharma USA, Inc.
$26
Foundation Medicine, Inc.
$24
Dendreon Pharmaceuticals LLC
$23
Pharmacyclics LLC, an AbbVie Company
$23
Taiho Oncology, Inc.
$20
Sysmex Inostics Inc
$19
Pharmacosmos Therapeutics Inc.
$18
TG THERAPEUTICS, INC.
$18
CTI BioPharma Corp.
$17
MorphoSys, US Inc.
$16
Janssen Pharmaceuticals, Inc
$15
CSL Behring
$15
Verastem, Inc.
$14
SERVIER PHARMACEUTICALS LLC
$14
Stemline Therapeutics Inc.
$14
Alexion Pharmaceuticals, Inc.
$14
MEDIVATION FIELD SOLUTIONS LLC
$13
Kyowa Kirin, Inc.
$12
Acrotech Biopharma LLC
$12
Veracyte, Inc.
$1
Top 3 companies account for 25.6% of all-time payments
Associated products mentioned in payments ›
ADCETRIS · AUGTYRO · AYVAKIT · Alecensa · Avastin · BAVENCIO · BELEODAQ · BESREMI · BLENREP · BOSULIF · BRUKINSA · CABOMETYX · CERDELGA · COSELA · Cabometyx · Columvi · Copiktra · DARZALEX · DOPTELET · ELIQUIS · ELITEK · ENHERTU · ERLEADA · Empaveli · Enhertu · Erivedge · Erleada · FOUNDATIONONE · Fabhalta · Folotyn · GAZYVA · IBRANCE · IMBRUVICA · INLYTA · INQOVI · Idelvion · Imbruvica · Inrebic · JAKAFI · KEYTRUDA · KISQALI · KRAZATI · Kadcyla · Kyprolis · LORBRENA · LUMAKRAS · LYNPARZA · Lenvima · MEKINIST · MONJUVI · MVASI · Marqibo · Nplate · OJJAARA · OPDIVO · OPDUALAG · OXBRYTA · Orserdu · PADCEV · PEMAZYRE · PIQRAY · POTELIGEO · PROMACTA · PROVENGE · Padcev · Perjeta · Pomalyst · REBLOZYL · RYBREVANT · Rezlidhia · SANDOSTATIN · SCEMBLIX · SOLIRIS · SYNDROS · TASIGNA · TECENTRIQ · TIVDAK · TUKYSA · Tavalisse · Tecentriq · Tibsovo · Trodelvy · UKONIQ · Udenyca · VENCLEXTA · VONJO · Vanflyta · Venclexta · Vonjo · XALKORI · XARELTO · XPOVIO · XTANDI · Xtandi · YONSA · Yescarta · ZEJULA · ZEPZELCA · ZOLADEX · Zoladex
Should you be concerned? Industry payments are disclosed through CMS Open Payments. Disclosure alone does not establish their purpose, legality, or effect on care. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Looking for a hematology specialist in Altamonte Springs?
Compare hematologists in the Altamonte Springs area by procedure volume, costs, and industry payment transparency.
Browse hematologists nearby

Geographic Context

Hematologists in nearby ZIP areas
17
County median income
$83,030
Nearest hospital to ZIP centroid (approximate)
ASPIRE HEALTH PARTNERS
7.4 mi

Data Sources

Provider Registry NPPES NPPES snapshot; verify current record
Medicare Enrollment PECOS PECOS snapshot
Practice Data Medicare Util. Annual (CY lag)
Industry Payments Open Payments CY 2024
Disciplinary History — Not included N/A

This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →

Summary

Gousse is a mixed practice specialist, with above-average Medicare volume (top 25% in FL), with 20 years of NPI registration.

This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →

Frequently Asked Questions

Is Gousse experienced with iron infusion (feraheme)?
Based on Medicare claims data, Gousse performed 66,300 iron infusion (feraheme) services. These records cover Medicare fee-for-service activity, including eligible younger beneficiaries; they do not measure total practice volume or clinical quality.
Does Gousse receive payments from pharmaceutical companies?
Yes. Gousse received a total of $7,813 from 62 companies across 411 payment records. A record can group multiple payments. These transfers are publicly disclosed through CMS Open Payments. Disclosure alone does not establish their legality or effect on care. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Gousse's costs compare to other hematologists in Altamonte Springs?
Gousse's average Medicare payment per service is $6. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Gousse) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating the presence of registry, enrollment, activity or payment records, not verified experience or clinical quality. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Source publication dates and the snapshots loaded on this site can differ. Rebuilding a page does not refresh its source records. Check the Medicare reporting year and the payment interval shown above; consult the linked official sources for newer releases and current registry details. See our data freshness policy →
About this page

This page combines public CMS records with calculated summaries and explanatory procedure labels. These transformations are not verbatim federal records. Sources: NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Industry payment disclosure alone establishes neither wrongdoing nor legality. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →